Evidence map›Paper›PMID 25824533›Full record

Trial reportBehaviour research and therapy2015

Change in obsessive-compulsive symptoms mediates subsequent change in depressive symptoms during exposure and response prevention.

Laurie J Zandberg, Yinyin Zang, Carmen P McLean, Rebecca Yeh, Helen Blair Simpson, Edna B Foa

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Behaviour research and therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder.The Psychiatric clinics of North America · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Laurie J ZandbergDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: zandberg@mail.med.upenn.edu.
Yinyin ZangDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Carmen P McLeanDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Rebecca YehDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Helen Blair SimpsonNew York State Psychiatric Institute, New York, NY, USA; Department of Psychiatry, Columbia University, New York, NY, USA.
Edna B FoaDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
University of Pennsylvania · USNew York Psychoanalytic Society and Institute · US

Funding

Maximizing Treatment Outcome in OCDR01MH045404 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI FOA, EDNA B · 1990 to 2016
$5.3M
Maximizing Treatment Outcome in OCDR01MH045436 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI SIMPSON, HELEN BLAIR · 1990 to 2015
$5.0M
NIMH NIH HHS R01 MH045404NIMH NIH HHS R01 MH045436NIMH NIH HHS R01 MH45404
6 · The paper itself

Abstract

objectiveThe current study examines the temporal relationship between changes in obsessive-compulsive symptoms and changes in depressive symptoms during exposure and response prevention (EX/RP) therapy for obsessive-compulsive disorder (OCD).

methodParticipants were 40 adults (53% female) who received EX/RP in a randomized controlled trial comparing serotonin reuptake inhibitor (SRI) augmentation strategies. Participants completed clinician-administered assessments of OCD (Yale-Brown Obsessive Compulsive Scale) and depressive symptoms (Hamilton Depression Rating Scale) every four weeks from baseline to 32-week follow-up.

resultsLagged multilevel mediational analyses indicated that change in OCD symptoms accounted for 65% of subsequent change in depressive symptoms. In contrast, change in depressive symptoms only partially mediated subsequent change in OCD symptoms, accounting for 20% of the variance in outcome.

conclusionsThese data indicate that reductions in co-morbid depressive symptoms during EX/RP for OCD are largely driven by reductions in obsessive-compulsive symptoms.

Indexed as

AdultCognitive Behavioral TherapyCombined Modality TherapyDepressionFemaleHumansImplosive TherapyMaleObsessive-Compulsive DisorderSelective Serotonin Reuptake InhibitorsSeverity of Illness IndexSelective Serotonin Reuptake InhibitorsCBTDepressionExposure and response preventionMediationObsessive-compulsive disorder

Identifiers

PMID25824533
PMCPMC4415155
OpenAlexW1979465678

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.